Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city.

Kavsak PA, Beattie J, Pickersgill R, Ford L, Caruso N, Clark L.

Pract Lab Med. 2015 Mar 3;1:28-34. doi: 10.1016/j.plabm.2015.02.001. eCollection 2015 Apr 1.

2.

Association Between High-Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women.

Lewis JR, Lim WH, Wong G, Abbs S, Zhu K, Lim EM, Thompson PL, Prince RL.

J Am Heart Assoc. 2017 Jul 30;6(8). pii: e004174. doi: 10.1161/JAHA.116.004174.

3.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.

Willeit P, Welsh P, Evans JDW, Tschiderer L, Boachie C, Jukema JW, Ford I, Trompet S, Stott DJ, Kearney PM, Mooijaart SP, Kiechl S, Di Angelantonio E, Sattar N.

J Am Coll Cardiol. 2017 Aug 1;70(5):558-568. doi: 10.1016/j.jacc.2017.05.062. Review.

4.

Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.

Kuller LH, Lopez OL, Gottdiener JS, Kitzman DW, Becker JT, Chang Y, Newman AB.

J Am Heart Assoc. 2017 Jul 22;6(7). pii: e005353. doi: 10.1161/JAHA.116.005353.

5.

N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.

Tanaka A, Yoshida H, Kawaguchi A, Oyama JI, Kotooka N, Toyoda S, Inoue T, Natsuaki M, Node K.

Sci Rep. 2017 Jul 19;7(1):5810. doi: 10.1038/s41598-017-06090-6.

6.

Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing.

Xiao W, Cao R, Liu Y, Wang F, Bai Y, Wu H, Ye P.

BMJ Open. 2017 Jun 26;7(6):e013431. doi: 10.1136/bmjopen-2016-013431.

7.

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.

Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L.

J Am Heart Assoc. 2017 Jun 23;6(6). pii: e004851. doi: 10.1161/JAHA.116.004851.

8.

Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population.

Shemisa K, Bhatt A, Cheeran D, Neeland IJ.

Curr Heart Fail Rep. 2017 Aug;14(4):301-310. doi: 10.1007/s11897-017-0342-z. Review.

PMID:
28639234
9.

High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.

Divard G, Abbas R, Chenevier-Gobeaux C, Chanson N, Escoubet B, Chauveheid MP, Dossier A, Papo T, Dehoux M, Sacre K.

Arthritis Res Ther. 2017 Jun 13;19(1):132. doi: 10.1186/s13075-017-1352-7.

10.

Physical Activity, Obesity, and Subclinical Myocardial Damage.

Florido R, Ndumele CE, Kwak L, Pang Y, Matsushita K, Schrack JA, Lazo M, Nambi V, Blumenthal RS, Folsom AR, Coresh J, Ballantyne CM, Selvin E.

JACC Heart Fail. 2017 May;5(5):377-384. doi: 10.1016/j.jchf.2017.02.002.

PMID:
28449797
11.

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

de Lemos JA, Ayers CR, Levine B, deFilippi CR, Wang TJ, Hundley WG, Berry JD, Seliger SL, McGuire DK, Ouyang P, Drazner MH, Budoff M, Greenland P, Ballantyne CM, Khera A.

Circulation. 2017 May 30;135(22):2119-2132. doi: 10.1161/CIRCULATIONAHA.117.027272. Epub 2017 Mar 30.

PMID:
28360032
12.

Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

Hamilton MJ, Robb Y, Cumming S, Gregory H, Duncan A, Rahman M, McKeown A, McWilliam C, Dean J, Wilcox A, Farrugia ME, Cooper A, McGhie J, Adam B, Petty R; Scottish Myotonic Dystrophy Consortium, Longman C, Findlay I, Japp A, Monckton DG, Denvir MA.

PLoS One. 2017 Mar 21;12(3):e0174166. doi: 10.1371/journal.pone.0174166. eCollection 2017. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175615.

13.

High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.

PMID:
28159799
14.

Measuring high-sensitivity cardiac troponin T blood concentration in population surveys.

Lazzarino AI, Mindell JS.

PLoS One. 2017 Jan 31;12(1):e0171242. doi: 10.1371/journal.pone.0171242. eCollection 2017.

15.

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Review. No abstract available. Erratum in: Circulation. 2017 Mar 7;135(10 ):e646. Circulation. 2017 Sep 5;136(10 ):e196.

16.

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.

Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E.

Diabetes Care. 2017 Feb;40(2):261-269. doi: 10.2337/dc16-1541. Epub 2016 Nov 15.

PMID:
28108537
17.

Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis.

van der Linden N, Klinkenberg LJ, Bekers O, Loon LJ, Dieijen-Visser MP, Zeegers MP, Meex SJ.

Medicine (Baltimore). 2016 Dec;95(52):e5703. doi: 10.1097/MD.0000000000005703.

18.

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.

Herrington W, Staplin N, Judge PK, Mafham M, Emberson J, Haynes R, Wheeler DC, Walker R, Tomson C, Agodoa L, Wiecek A, Lewington S, Reith CA, Landray MJ, Baigent C; SHARP Collaborative Group.

Hypertension. 2017 Feb;69(2):314-322. doi: 10.1161/HYPERTENSIONAHA.116.08386. Epub 2016 Dec 27.

19.

Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.

Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A.

JACC Heart Fail. 2017 Jan;5(1):56-63. doi: 10.1016/j.jchf.2016.10.010. Epub 2016 Dec 21.

PMID:
28017350
20.

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.

Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, Newby DE, Packard CJ, Mills NL.

J Am Coll Cardiol. 2016 Dec 27;68(25):2719-2728. doi: 10.1016/j.jacc.2016.10.020.

Supplemental Content

Support Center